Antitumor activity of 1,2-diaminocyclohexane--platinum complexes against sarcoma-180 ascites form.
Platinum complexes derived from three isomers of 1,2-diaminocyclohexane have been synthesized and their antitumor activities were evaluated against ascites Sarcoma-180. All the platinum complexes had high antitumor activity. Platinum complexes derived from cis-1,2-diaminocyclohexane were more effective than those derived from trans-l-and trans-d-1,2-diaminocyclohexane. Among the platinum complexes tested, oxalato(cis-1,2-diminocyclohexane)platinum had a remarkably high therapeutic index. Modification of the nonleaving group as well as that of the leaving group is important in order to find better antitumor platinum complexes.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D007536:Isomerism; D051379:Mice; D008815:Mice, Inbred Strains; D008968:Molecular Conformation; D010984:Platinum / Q000494:pharmacology* / Q000627:therapeutic use; D012510:Sarcoma 180 / Q000188:drug therapy*; D012995:Solubility; D013237:Stereoisomerism; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D010984:Platinum